Event ContactsPaid membership required to see this information
The goal of the 14th International Lung Cancer Congress® is to provide physicians with practical information regarding tobacco cessation, lung cancer staging, the latest clinical data impacting the treatment of lung cancer, and novel agents and strategies that will shape the future of lung cancer therapy. The importance of personalized therapy will be emphasized, followed by other current topics of interest. State-of-the-art treatment for non–small-cell lung cancer (NSCLC) by stage, SCLC, and mesothelioma will be discussed. Didactic lectures and case-based panel discussions will be used to reinforce current standards and to present emerging clinical data. Panel discussions, multidisciplinary tumor boards, and question-and-answer sessions will allow the faculty to share their personal experiences and opinions on specific clinical scenarios and ongoing controversies in the treatment of lung cancer. Furthermore, a recurring session will highlight clinical research activity of Cooperative Groups in the United States, Europe, and Asia. This will provide invaluable education to the practicing physician to increase their knowledge and improve their performance in managing patients with lung cancer.
- International Strategies for Tobacco Cessation
- Impact and Application of the IASLC Staging Project
- ALK inhibitors
- MET inhibitors
- Emerging agents workshop
- Biomarkers for Personalized Lung Cancer Therapy / Next Generation Sequencing for Molecular Profiling
- Maintenance Therapy for Lung Cancer
- International Cooperative Group Update
- Case-based panel discussions and multidisciplinary tumor board
Don't wait to register for the 14th International Lung Cancer Congress. You'll meet influential people and maximize your opportunities for success. Start now by accessing the information below.
|Conference/Event Dates:||07/25/2013 - 07/27/2013|
|Expo/Exhibit Dates:||07/25/2013 - 07/27/2013|
|Other Industries:||Cancer, Oncology-Hematology, Professional Healthcare, Pulmonary|
|Audience:||This educational activity is directed toward medical, surgical and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers and other healthcare professionals interested in the treatment of lung cancer are also invited to attend.|
|Venue:||Hyatt Regency Huntington Beach|
|Venue Phone:||(714) 845-4889|
|Venue Type:||Indoor - Hotel|
|Official Conference Hotel:||Hyatt Regency Huntington Beach|
|Conference Hotel URL:||www.huntingtonbeach.hyatt.com...|
|Sponsorship Details:||For details, contact:
Jill Goldberg, Director of Sponsorships for Intellisphere - Liaison to PER
Intellisphere, LLC | Oncology Group
|Booth Size||Booth Cost||Available Amenities|
|Call for information.||Electricity:||n/a|
|Marketing Vehicles Allowed:||Call|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.